An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis
- PMID: 19576851
- PMCID: PMC4718191
- DOI: 10.1016/S1470-2045(09)70164-0
An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis
Abstract
Background: Phaeochromocytomas and paragangliomas are neuro-endocrine tumours that occur sporadically and in several hereditary tumour syndromes, including the phaeochromocytoma-paraganglioma syndrome. This syndrome is caused by germline mutations in succinate dehydrogenase B (SDHB), C (SDHC), or D (SDHD) genes. Clinically, the phaeochromocytoma-paraganglioma syndrome is often unrecognised, although 10-30% of apparently sporadic phaeochromocytomas and paragangliomas harbour germline SDH-gene mutations. Despite these figures, the screening of phaeochromocytomas and paragangliomas for mutations in the SDH genes to detect phaeochromocytoma-paraganglioma syndrome is rarely done because of time and financial constraints. We investigated whether SDHB immunohistochemistry could effectively discriminate between SDH-related and non-SDH-related phaeochromocytomas and paragangliomas in large retrospective and prospective tumour series.
Methods: Immunohistochemistry for SDHB was done on 220 tumours. Two retrospective series of 175 phaeochromocytomas and paragangliomas with known germline mutation status for phaeochromocytoma-susceptibility or paraganglioma-susceptibility genes were investigated. Additionally, a prospective series of 45 phaeochromocytomas and paragangliomas was investigated for SDHB immunostaining followed by SDHB, SDHC, and SDHD mutation testing.
Findings: SDHB protein expression was absent in all 102 phaeochromocytomas and paragangliomas with an SDHB, SDHC, or SDHD mutation, but was present in all 65 paraganglionic tumours related to multiple endocrine neoplasia type 2, von Hippel-Lindau disease, and neurofibromatosis type 1. 47 (89%) of the 53 phaeochromocytomas and paragangliomas with no syndromic germline mutation showed SDHB expression. The sensitivity and specificity of the SDHB immunohistochemistry to detect the presence of an SDH mutation in the prospective series were 100% (95% CI 87-100) and 84% (60-97), respectively.
Interpretation: Phaeochromocytoma-paraganglioma syndrome can be diagnosed reliably by an immunohistochemical procedure. SDHB, SDHC, and SDHD germline mutation testing is indicated only in patients with SDHB-negative tumours. SDHB immunohistochemistry on phaeochromocytomas and paragangliomas could improve the diagnosis of phaeochromocytoma-paraganglioma syndrome.
Funding: The Netherlands Organisation for Scientific Research, Dutch Cancer Society, Vanderes Foundation, Association pour la Recherche contre le Cancer, Institut National de la Santé et de la Recherche Médicale, and a PHRC grant COMETE 3 for the COMETE network.
Conflict of interest statement
The authors declared no conflicts of interest.
Figures



Comment in
-
Diagnosing patients with hereditary paraganglial tumours.Lancet Oncol. 2009 Aug;10(8):741. doi: 10.1016/S1470-2045(09)70204-9. Lancet Oncol. 2009. PMID: 19647193 Review. No abstract available.
Similar articles
-
Potential Pitfalls of SDH Immunohistochemical Detection in Paragangliomas and Phaeochromocytomas Harbouring Germline SDHx Gene Mutation.Anticancer Res. 2017 Feb;37(2):805-812. doi: 10.21873/anticanres.11381. Anticancer Res. 2017. PMID: 28179334
-
Novel succinate dehydrogenase subunit B (SDHB) mutations in familial phaeochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic phaeochromocytomas.Oncogene. 2003 Mar 6;22(9):1358-64. doi: 10.1038/sj.onc.1206300. Oncogene. 2003. PMID: 12618761
-
SDH mutations in tumorigenesis and inherited endocrine tumours: lesson from the phaeochromocytoma-paraganglioma syndromes.J Intern Med. 2009 Jul;266(1):19-42. doi: 10.1111/j.1365-2796.2009.02111.x. J Intern Med. 2009. PMID: 19522823 Free PMC article. Review.
-
Tumour risks and genotype-phenotype correlations associated with germline variants in succinate dehydrogenase subunit genes SDHB, SDHC and SDHD.J Med Genet. 2018 Jun;55(6):384-394. doi: 10.1136/jmedgenet-2017-105127. Epub 2018 Jan 31. J Med Genet. 2018. PMID: 29386252 Free PMC article.
-
Familial paraganglioma syndromes.J Clin Pathol. 2010 Jun;63(6):488-91. doi: 10.1136/jcp.2010.076257. J Clin Pathol. 2010. PMID: 20498024 Review.
Cited by
-
Novel alternative tools for metastatic pheochromocytomas/paragangliomas prediction.J Endocrinol Invest. 2024 May;47(5):1191-1203. doi: 10.1007/s40618-023-02239-5. Epub 2024 Jan 11. J Endocrinol Invest. 2024. PMID: 38206552 Clinical Trial.
-
Gastrointestinal Malignancy: Genetic Implications to Clinical Applications.Cancer Treat Res. 2024;192:305-418. doi: 10.1007/978-3-031-61238-1_15. Cancer Treat Res. 2024. PMID: 39212927 Review.
-
Paraganglioma of seminal vesicle and chromophobe renal cell carcinoma: a case report and literature review.Sao Paulo Med J. 2012;130(1):57-60. doi: 10.1590/s1516-31802012000100010. Sao Paulo Med J. 2012. PMID: 22344361 Free PMC article. Review.
-
Germline c.1A>C heterozygous pathogenic variant in SDHA reported for the first time in a young adult with a gastric gastrointestinal stromal tumour (GIST): a case report.Hered Cancer Clin Pract. 2019 Aug 9;17:23. doi: 10.1186/s13053-019-0124-6. eCollection 2019. Hered Cancer Clin Pract. 2019. PMID: 31413764 Free PMC article.
-
Risk Stratification on Pheochromocytoma and Paraganglioma from Laboratory and Clinical Medicine.J Clin Med. 2018 Aug 27;7(9):242. doi: 10.3390/jcm7090242. J Clin Med. 2018. PMID: 30150569 Free PMC article. Review.
References
-
- Lenders JW, Eisenhofer G, Mannelli M, Pacak K. Phaeochromocytoma. Lancet. 2005;366:665–75. - PubMed
-
- Karagiannis A, Mikhailidis DP, Athyros VG, Harsoulis F. Phaeochromocytoma: an update on genetics and management. Endocr Relat Cancer. 2007;14:935–56. - PubMed
-
- Nakamura E, Kaelin WG., Jr Recent insights into the molecular pathogenesis of phaeochromocytoma and paraganglioma. Endocr Pathol. 2006;17:97–106. - PubMed
-
- Amar L, Bertherat J, Baudin E, et al. Genetic testing in phaeochromocytoma or functional paraganglioma. J Clin Oncol. 2005;23:8812–18. - PubMed
-
- Lancaster CR. Succinate:quinone oxidoreductases: an overview. Biochim Biophys Acta. 2002;1553:1–6. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials